Home News Drug Research

Drug Research

Indian Health Ministry Ends Repeat Animal Testing for Drugs

New Delhi, March 21, 2016: Repeat animal testing of new drugs already tested abroad is now banned per a ruling today by the Union Ministry of Health and Family Welfare. The ban falls under amendment Schedule Y, in the Appendix...

Sanofi Signs Agreement with Mannkind Corp to Develop and Market Insulin Inhaler

New Delhi, August 13, 2014 - French drugmaker Sanofi is trying to build insulin inhaler that would help diabetics from the requirement of taking insulin injections. For the same, Sanofi has signed a worldwide licensing agreement with MannKind Corp...

Cyclopharm Ltd, Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW...

Name : Cyclopharm Ltd Address : Bldg 75 Business & Technology Park New Illawarra Road Lucas Heights NSW 2234 Australia PO Box 350, Menai Central NSW 2234 Australia Tel No: 61 2 9541 0411 Email : enquiries@cyclopharm.com.au...

Sandoz Inc recalls India-made anti-allergic tablets in US

New Delhi, June 12, 2015: Drug firm Sandoz Inc is recalling India-made 1,023,430 units of anti-allergic Cetirizine HCl chewable tablets in the US due to impurity concerns. According to information on the USFDA site, the recall is for Cetirizine HCl...

Aurobindo Pharma receives final approvals for Nafcillin Injections

Aurobindo Pharma Limited is pleased to announce that the company has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Nafcillin for Injection USP, packaged in 1g and 2g vials (ANDA 091613) and  Nafcillin for Injection USP 10g/Vial Pharmacy Bulk Package (ANDA 091614). The products are ready for launch. Nafcillin for Injection is a sterile semisynthetic  penicillin (SSP) indicated in the treatment of infections caused by penicillinase-producing staphylococci which have demonstrated susceptibility to the drug. It may be used to initiate therapy in  suspected cases of resistant staphylococcal infections prior to the availability of susceptibility test results.

Combined Medical Services Examination, 2013

New Delhi March 5, 2014:- Based on the results of the Combined Medical Services written examination 2013 held by the UNION PUBLIC SERVICE COMMISSION on June 30,2013 and the interviews for Personality Test held in November-December 2013, the following...

Advanced rheumatoid arthritis medicine developed in Russia

New Delhi, July 22, 2016: Biotechnological company BIOCAD has developed innovative medicine for treatment of rheumatoid arthritis (RA), psoriatic arthritis (PsA) and other autoimmune diseases. According to scientists forecast, the new drug candidate (BCD-121) can increase the efficacy of treatment...

Dr Reddy’s initiates recall of two drugs in US

Recall of anti-seizure drug, Divalproex, involved four lots of bottles containing different counts and strength of tablets Hyderabad, July 01, 2015 - A year after the last recall of its generic hypertension drug Metroprolol, Hyderabad-based Dr Reddy's Laboratories Limited has...

Ranbaxy doubts staff involvement behind issues at Toansa plant

Mumbai February 10, 2013:- After the US Food and Drug Administration (USFDA) raised concerns over Ranbaxy’s largest drug ingredient plant at Toansa, many questions regarding the GMP compliance have come up. The company is making every attempt to investigate...

PLAC Test to Determine Cardiovascular Diseases

Mumbai July 10, 2014: Metropolis Healthcare Ltd, India’s leading multinational chain of diagnostic centers has become one of the few laboratories in Asia to offer PLAC Test. It is a risk stratification test which identifies the enzyme in the...